Tenax Therapeutics (TENX) Change in Interest Receivables (2020 - 2022)
Tenax Therapeutics recorded quarterly Change in Interest Receivables of -$1484.0 in Q2 2022, up 42.64% quarter-over-quarter from -$2587.0 in Q1 2022, and down 341.67% year-over-year from $614.07 in Q2 2021.
Tenax Therapeutics' Change in Interest Receivables history runs 3 years deep, the most recent figure standing at -$1484.0 for Q2 2022.
- In Q2 2022, Change in Interest Receivables fell 341.67% year-over-year to -$1484.0; the TTM figure through Jun 2022 stood at -$4071.0 (down 36.52% YoY), while the FY2021 annual figure was -$949.0, up 41.67% from the prior year.
- Change in Interest Receivables came in at -$1484.0 for Q2 2022 at Tenax Therapeutics, up from -$2587.0 in the prior quarter.
- In the past five years, Change in Interest Receivables ranged from a high of $1898.0 in Q3 2021 to a low of -$2643.0 in Q4 2020.
- A 3-year average of -$738.56 and a median of -$613.0 in 2021 frame the typical range for Change in Interest Receivables.
- Across the five-year window, Change in Interest Receivables soared 211.15% in 2021 and tumbled 341.67% in 2022, its largest moves.
- Tenax Therapeutics' Change in Interest Receivables stood at -$2643.0 in 2020, then advanced by 28.19% to -$1898.0 in 2021, then rose by 21.81% to -$1484.0 in 2022.
- According to Business Quant data, Change in Interest Receivables over the past three periods registered -$1484.0, -$2587.0, and -$1898.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -1,484.00 |
| Mar 31, 2022 | -2,587.00 |
| Dec 31, 2021 | -1,898.00 |
| Sep 30, 2021 | 1,898.00 |
| Jun 30, 2021 | -336.00 |
| Mar 31, 2021 | -613.00 |
| Dec 31, 2020 | -2,643.00 |
| Sep 30, 2020 | 610.00 |
| Jun 30, 2020 | 406.00 |